PIQUR Therapeutics AG
8 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Study of Oral PQR309 in Patients With Advanced Solid Tumors (NCT02483858) | PIQUR Therapeutics AG | 2019-03-21 |
| PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma (NCT03120000) | PIQUR Therapeutics AG | 2017-12-01 |
Track PIQUR Therapeutics AG automatically
Every clearance here is in the API, with alerts when new ones post.